Streetbeat News

Products Services

CDIO

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) has been assigned a dedicated CPT PLA code by the AMA for its AI-driven CHD detection test, PrecisionCHD. This code is crucial for securing reimbursement and broadening access to the test. PrecisionCHD, which uses genetic-epigenetic analysis and AI, aims to improve CHD diagnosis and patient outcomes while reducing healthcare costs. The test's scalability and remote deployment capabilities can enhance care delivery, especially in underserved areas. The innovation of PrecisionCHD has been recognized in a study and by Vizient, Inc.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 1:42 pm

SDIG

Stronghold Digital Mining (SDIG) has executed agreements to purchase 5,000 Bitcoin miners for approximately $8.5 million on December 26, 2023. These miners have a total hash rate capacity of around 600 PH/s and an average efficiency of 25 J/T. Delivery is expected in January 2024. Additionally, Stronghold has an option to buy 2,500 Canaan Avalon A1466 Bitcoin miners with a total hash rate capacity of 360 PH/s and an expected efficiency of 21.5 J/T. The company also provided an update on its Bitcoin mining operations for December.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 1:39 pm

RIVN

Rivian Automotive, Inc. (NASDAQ:RIVN) exceeded its FY23 production guidance by producing 57,232 vehicles against the forecast of 54,000. Q4 saw 17,541 vehicles produced and 13,972 delivered. The company will release Q4 and FY23 financial results on February 21st, with a webcast to discuss performance and outlook.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 1:39 pm

KTTA

Pasithea Therapeutics has announced that the FDA has accepted its Investigational New Drug (IND) application for PAS-004, which is intended for evaluation in advanced cancer patients. This acceptance marks a significant milestone for the company as it can now proceed with clinical trials to assess the safety and efficacy of PAS-004 in this patient population.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 1:39 pm

IINN

Inspira Technologies (NASDAQ:IINN) has signed a non-binding Letter of Intent with Northwestern Memorial Hospital for the clinical use of its INSPIRA ART100 device, pending FDA clearance. The collaboration will involve Northwestern purchasing disposables for the device and providing usage data to Inspira Technologies. The agreement is contingent on FDA approval expected in the first half of 2024 and a definitive evaluation agreement.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 1:37 pm

DXR

Daxor Corporation has submitted its new Blood Volume Analyzer (BVA) system to the FDA for clearance, with expectations for potential approval in the first half of 2024. The new BVA system is designed to deliver faster, simpler, and bedside results, aligning with the company's mission to improve healthcare through optimal fluid management.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 1:33 pm

CHRS

Coherus BioSciences, Inc. (NASDAQ: CHRS) has launched LOQTORZI, the first and only FDA-approved treatment for nasopharyngeal carcinoma (NPC) in all lines of therapy. LOQTORZI is now available through select specialty distributors and is indicated for use in combination with chemotherapy for first-line treatment and as monotherapy for patients with disease progression after platinum-containing chemotherapy. The launch follows positive results from the JUPITER-02 and POLARIS-02 studies, which showed significant improvements in progression-free survival and overall survival. Coherus aims to make LOQTORZI the new standard of care for NPC and is committed to supporting patients with programs to reduce out-of-pocket costs.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 1:31 pm

GOOG

GOOGL

Alphabet Inc.'s Google Bard, a ChatGPT rival, is seeking user feedback for its 2024 wishlist. Requests include a standalone app, integration with Google Assistant, reduced censorship, fewer hallucinations, and persistent memory. Google is already working on Assistant integration, announced during the Pixel launch in Oct. 2023. A standalone app could benefit iOS users since Google Assistant isn't pre-installed on iOS devices. Persistent memory would help in tasks like debugging code or writing extended texts. Google Bard aims to compete with ChatGPT by adding consumer-facing features.

Portfolio Pulse from Rounak Jain

January 02, 2024 | 1:27 pm

BABA

PDD

Alibaba Group Holding Limited (BABA) is facing significant challenges, including a loss of direction, regulatory issues, and declining staff morale. The company was overtaken in market capitalization by PDD Holdings Inc (PDD) and its shares are now 75% off their peak. Alibaba's new CEO, Eddie Yongming Wu, is tasked with consolidating control over its diverse businesses. The company's restructuring efforts and competition from ByteDance's Douyin and PDD's Pinduoduo and Temu add to its struggles. Alibaba's growth strategy is unclear, with mixed signals from dividends and share buybacks, and uncertainty around its fintech affiliate Ant and logistics arm Cainiao's IPO. BABA shares traded lower by 2.01% at $75.95 in premarket trading.

Portfolio Pulse from Anusuya Lahiri

January 02, 2024 | 1:21 pm

NIO

NIO Inc. (NYSE:NIO) shares are down in premarket trading despite the company reporting a 13.9% year-over-year increase in vehicle deliveries for December 2023. The company also launched the ET9, a smart electric executive flagship, and expects to start deliveries in Q1 2025. NIO recently secured a $2.2 billion investment from CYVN Holdings, giving CYVN a 20.1% ownership stake. The investment is aimed at enhancing NIO's balance sheet to improve brand positioning, sales, service capabilities, and investment in core technologies.

Portfolio Pulse from Nabaparna Bhattacharya

January 02, 2024 | 1:21 pm